Aurobindo’s latest generic product is showcasing its versatility of delivery methods. The company is introducing its azelastine hydrochloride nasal spray 0.1%, a generic of Astelin.
The generic is Aurobindo’s first product launch in the United States using a pump nasal spray delivery system, highlighting its ongoing strategic push into alternative delivery systems. Besides the pump nasal sprays, these alternative delivery systems include metered-dose inhalers, prefilled syringes and transdermal patches.
Azelastine hydrochloride nasal spray 0.1% had a market value of $54.8 million for the year ended January 2021, according to data from IQVIA.